SLP-2 overexpression could serve as a prognostic factor in node positive and HER2 negative breast cancer

Pathology

Volumn 43, Issue 7, 2011, Pages 713-718

  Cao, Wenfeng ^a,b   Zhang, Bin ^a   Li, Jin ^c   Liu, Yanxue ^a   Liu, Zhihua ^b   Sun, Baocun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breast cancer; HER2 neu; Node positive; Prognosis; SLP 2

Indexed keywords

EID: 84863296041     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e32834c34ed     Document Type: Article

References (16)

1. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869-74. (Pubitemid 32878711)
2. Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer 2010; 17: R245-62.
3. Wang Y, Morrow JS. Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues. J Biol Chem 2000; 275: 8062-71. (Pubitemid 30159719)
4. Luo A, Kong J, Hu G, et al. Discovery of Ca2θ-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 2004; 23: 1291-9. (Pubitemid 38297184)
5. Lu J, Liu Z, Xiong M, et al. Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 2001; 91: 288-94. (Pubitemid 32049620)
6. Zhang L, Ding F, Cao W, et al. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Clin Cancer Res 2006; 12: 1639-46.
7. Cao WF, Zhang LY, Liu MB, et al. Prognostic significance of stomatin-like protein 2 overexpression in laryngeal squamous cell carcinoma: clinical, histologic, and immunohistochemistry analyses with tissue microarray. Hum Pathol 2007; 38: 747-52.
8. Zhang LY, Ding F, Liu ZM, et al. Effect of stomatin-like protein 2 (SLP-2) gene on growth and proliferation of esophageal squamous carcinoma cell line TE12. (Chinese.) Ai Zheng 2005; 24: 155-9.
9. Cui Z, Zhang L, Hua Z, et al. Stomatin-like protein 2 is overexpressed and related to cell growth in human endometrial adenocarcinoma. Oncol Rep 2007; 17: 829-33.
10. Cao W, Zhang B, Liu Y, et al. High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival. Am J Clin Pathol 2007; 128: 430-6. (Pubitemid 47479976)
11. Onitilo AA, Engel JM, Greenlee RT, et al. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 2009; 7: 4-13.
12. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; 25: 118-45. (Pubitemid 350003059)
13. Tavernarakis N, Driscoll M, Kyrpides NC. The SPFH domain: implicated in regulating targeted protein turnover in stomatins and other membrane-associated proteins. Trends Biochem Sci 1999; 24: 425-7. (Pubitemid 29528200)
14. Wang Y, Cao W, Yu Z, et al. Downregulation of a mitochondria associated protein SLP-2 inhibits tumor cell motility, proliferation and enhances cell sensitivity to chemotherapeutic reagents. Cancer Biol Ther 2009; 8: 1651-8.
15. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-52.
16. Hugh J, Hanson J, Cheang MC, et al. Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial. J Clin Oncol 2009; 27: 1168-76.